Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen) - PubMed (original) (raw)

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

T Hara et al. J Exp Med. 1985.

Abstract

In previous studies (17-21), monoclonal antibody (mAb) 9.3 has been shown to react with a major population of human T cells, which include T4+ helper/inducer T cells and T8+ cytotoxic T cells. In this investigation, mAb 9.3 was shown to precipitate a disulfide-bonded dimer of a 44 kD polypeptide. Comodulation experiments showed that this molecule is not linked to T3/Ti or T11 antigens. mAb 9.3 was capable of inducing T cell proliferation in the presence of 12-o-tetradecanoyl phorbol-13-acetate (TPA). This effect was monocyte-independent. T cell activation with mAb 9.3 and TPA was associated with increases in interleukin 2(IL-2) receptor expression and IL-2 secretion. mAb 9.3 did not activate T cells, even with the addition of IL-1 or IL-2. Modulation of the T3 complex did not abolish mAb 9.3-induced T cell proliferation in the presence of TPA. These results suggest that the 9.3 antigen may serve as a receptor for an activation pathway restricted to a T cell subset.

PubMed Disclaimer

References

    1. Clin Immunol Immunopathol. 1980 Mar;15(3):301-13 - PubMed
    1. J Immunol. 1981 Aug;127(2):448-52 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5096-8 - PubMed
    1. Cell Immunol. 1982 Sep 1;72(1):122-9 - PubMed
    1. J Exp Med. 1982 Dec 1;156(6):1860-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources